Feasibility study of neoadjuvant chemoradiotherapy using Intensity Modulated Radiation Therapy (IMRT) with Docetaxel, CDDP and 5-Fluorouracil (DCF) for cervical esophageal cancer.

Feasibility study of neoadjuvant chemoradiotherapy using Intensity Modulated Radiation Therapy (IMRT) with Docetaxel, CDDP and 5-Fluorouracil (DCF) for cervical esophageal cancer. - OCD1501

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000018241

Enrollment

Registered

2015-07-09

Start date

2015-05-14

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cervical esophageal cancer

Interventions

Intensity Modulated Radiation Therapy (IMRT)with Docetaxcel/CDDP/5-FU(DCF)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Histologically proven cervical esophageal cancer 2) Tumor progress range/cervical esophageal cancer: Ce, CePh 3) Tumor progress range/TNM: T1b,T2,T3,T4 4) Aged over 20 years at the time of registration Performance Status(ECOG):0 or 1 5) Adequate organ function 6) Written IC

Exclusion criteria

Exclusion criteria: 1) History of serious drug hypersensitivity 2) Pregnant, lactating or women of child-bearing potential. Men who want get partner pregnant 3) Active infections 4 4) Serious complications 5) Serious heart disease 6) Peptic ulcers 7) Sensory neuropathy 8) Diarrhea 9) A case with abdominal dropsy and the hydrothorax to need a treatment 10) Brain metastasis 11) Other active malignancies (Nondisease period less than 5 years) 12) Continuous steroid treatment 13) Any other cases who are regarded as inadequate for study enrollment by the investigator 14) Administration contraindication of 5-FU, CDDP, Docetaxel

Design outcomes

Primary

Measure	Time frame
tbc	—

Countries

Japan

Contacts

Public ContactMakoto Sakai

Gunma University Hospital Integrative Center of General Surgery

maksakai@gunma-u.ac.jp027-220-8224

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026